The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Registration and Reporting Guidelines for Clinical Trials

임상시험 등록시스템 및 연구결과 보고지침

  • Kim, Seong-Eun (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • Published : 2012.09.01
⟨ Previous Next ⟩

Abstract

Selective outcome reporting is a major problem because it has a negative impact on our scientific knowledge and is unethical as it involves research on human subjects. And inadequate quality of trials may distort the results from systematic reviews and meta-analyses. Thus, Clinical medicine tries to solve the problem of trials by making public registration before patient enrollment mandatory and encouraging to report the research outcomes by a specific guidelines. In the past few years, the registration of clinical trials and the reporting system has become routine, supported by the International Committee of Medical Journal Editors. In Korea, the clinical research registry named 'Clinical Research Information Service (CRiS)' was recently established and became a data provider as a primary registry to the World Health Organization (WHO) International Clinical Trial Registry Platform search portal. To expand the registration system and to operate them successfully and comprehensively, active participations of researchers as well as the government supports are required.

Keywords

References

  1. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 2004;141:477-478. https://doi.org/10.7326/0003-4819-141-6-200409210-00109
  2. International committee of medical journal of editors (ICMJE). Uniform requirements for manuscripts submitted to biomedical journals: publishing and editorial issues related to publication in biomedical journals: obligation to register clinical trials [Internet]. Philadelphia,: ICMJE, c2009[cited 30 Jul 2012]. Available from: http://www.icmje.org/publishing_10register. html.about.html
  3. Kim SY. Selective reporting and clinical trial registry. Korean J Fam Med 2009;30:923.
  4. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986;4:1529-1541.
  5. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-2465. https://doi.org/10.1001/jama.291.20.2457
  6. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-1389. https://doi.org/10.1001/jama.1990.03440100097014
  7. Park HY. Primary registry of the WHO International Clinical Trial Registry Platform: Clinical Research Information Service (CRIS). J Korean Med Assoc 201154:92-97.
  8. Clinical Trials.gov. [Internet]. Bethesda: ClinicalTrials.gov, c2007 [cited 2012 Jul 28]. Available form: http://www.linicaltrial.gov/ct2/info/about.
  9. World Medical Association. WMA declaration of Helsinkiethical principles for medical research involving human subjects [Internet]. Paris: World Medical Association, c2010 [cited 2010 Jul 8]. Available from: http://www.wma.net/en/ 30publications/10policies/b3/index.html.
  10. World Health Organization. International Clinical Trials Registry Platform: WHO data set [Internet]. Geneva: World Health Organization, c2008 [cited 2010 Dec 31]. Available from: http://www.who.int/ictrp/network/primary/en/index.html.
  11. Tse T, Williams RJ, Zarin DA. Reporting "basic results" in ClinicalTrials.gov. Chest 2009;136:295-303. https://doi.org/10.1378/chest.08-3022
  12. CRiS website. Clinical Research information Service [Internet] Chungwon‐gun: Korea Centers for Disease Control and Prevention, c2011 [cited 2012 Jul 30].Available form http://cris.cdc.go.kr/
  13. Park HY. Reporting guidelines for research outcomes: STROBE and CONSORT guideline. Intest research 2010 8(Suppl 1): S14-S16.
  14. STROBE statement. [Internet]. Bern: STROBE statement, c2009 [cited 2012 Jul 30]. Available from: http://www.strobestatement. org.
  15. Enhancing the Quality and Transparency Of health Research. equator network [Internet]. Enhancing the Quality and Transparency Of health Research, c2011 [cited 2012 Jul 31]. Available from:http://www.equator‐network.org.
  16. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335:149-153. https://doi.org/10.1016/0140-6736(90)90014-V
  17. Hotopf M, Lewis G, Normand C. Putting trials on trial: the costs and consequences of small trials in depression: a systematic review of methodology. JEpidemiol Community Health 199751:354-358. https://doi.org/10.1136/jech.51.4.354
  18. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-639. https://doi.org/10.1001/jama.1996.03540080059030
  19. Moher D, Schulz KF, Altman D; CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285:1987-1991. https://doi.org/10.1001/jama.285.15.1987
  20. CONSORT statement. [Internet]. Oxfod: CONSORT statement, c2007 [cited 2002 Jul 29]. Available from: http://www. consort-statement.org.
  21. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. https://doi.org/10.1136/bmj.c332
  22. Moher D, Jones A, Lepage L; CONSORT Group (Consolitdated Standards for Reporting of Trials). Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 2001;285:1992-1995. https://doi.org/10.1001/jama.285.15.1992
  23. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials 2008;9:20. https://doi.org/10.1186/1745-6215-9-20
  24. Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthal 2009;116:286-296. https://doi.org/10.1016/j.ophtha.2008.09.014

Cited by

  1. Need for Clinical Trial Registry and Institutional Review Board Approval in Human Subjects Research vol.34, pp.1, 2013, https://doi.org/10.4082/kjfm.2013.34.1.1
  2. Consolidated Standards of Reporting Trials의 소개: 무작위 대조군 연구의 보고 지침 vol.14, pp.3, 2012, https://doi.org/10.17135/jdhs.2014.14.3.269